Revolutionary Malaria Vaccine for Infants: A Leap Towards Eradicating Childhood Deaths
New Study Reveals R21/Matrix-M Vaccine's High Efficacy in Protecting Young Children Against Malaria
Topline:
A groundbreaking phase 3 study unveils that the new R21/Matrix-M malaria vaccine offers protection rates of 68%-75% in children under 1.5 years, marking a significant stride in malaria prevention and promising to fill the global demand for effective vaccines.
